Medicare Enrolled

Dr. Matthew Benz, MD

Ophthalmology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
6560 FANNIN ST, Houston, TX 77030
7135243434
In practice since 2006 (19 years)
NPI: 1689771545 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Benz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Benz

Dr. Matthew Benz is an ophthalmology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benz performed 22,777 Medicare services across 3,921 unique beneficiaries.

Between the years covered by Open Payments, Dr. Benz received a total of $14,965 from 14 pharmaceutical and/or device companies across 73 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Benz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in TX $14,965 industry payments

Medicare Practice Summary

Medicare Utilization ↗
22,777
Medicare services
Top 4% in TX for ophthalmology
3,921
Unique beneficiaries
$249
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,199 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Aflibercept eye injection (Eylea) 4,898 $691 $2,705
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
4,021 $29 $112
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,296 $30 $127
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
2,985 $120 $451
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
2,551 $104 $493
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,885 $91 $396
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
1,648 $219 $847
Injection, ranibizumab, 0.1 mg 440 $154 $775
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
237 $1,827 $7,135
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
184 $1,976 $7,533
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
180 $26 $116
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
115 $105 $469
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
97 $102 $394
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
75 $122 $521
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
67 $73 $344
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
58 $70 $280
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $93 $400
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
17 $204 $885
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,965
Total received (2018-2024)
Avg $2,138/year across 7 years
Top 9% in TX for ophthalmology
14
Companies
73
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,357 (82.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,608 (17.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$265
2023
$287
2022
$469
2021
$61
2020
$68
2019
$6,932
2018
$6,884

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan Inc.
$5,725
AbbVie, Inc.
$4,784
Regeneron Pharmaceuticals, Inc.
$3,000
Genentech USA, Inc.
$403
Apellis Pharmaceuticals, Inc.
$284
Regeneron Healthcare Solutions, Inc.
$277
Coherus Biosciences Inc.
$125
Biogen, Inc.
$105
EyePoint Pharmaceuticals US, Inc.
$68
Novartis Pharmaceuticals Corporation
$58
AbbVie Inc.
$52
Alimera Sciences, Inc.
$36
Astellas Pharma US Inc
$31
ABBVIE INC.
$16
Top 3 companies account for 90.3% of total payments
Associated products mentioned in payments ›
ADUHELM · BROLUCIZUMAB · BYOOVIZ · Cimerli · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Iluvien · Lucentis · Nimbex · OZURDEX · Syfovre · VABYSMO · Vabysmo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for ophthalmology in TX.

Equivalent to $66 per 100 Medicare services performed
Looking for an ophthalmology specialist in Houston?
Compare ophthalmologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
298
Per 100K population
6.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Benz is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with consulting-driven industry engagement in the top 9% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Benz experienced with aflibercept eye injection (eylea)?
Based on Medicare claims data, Dr. Benz performed 4,898 aflibercept eye injection (eylea) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benz receive payments from pharmaceutical companies?
Yes. Dr. Benz received a total of $14,965 from 14 companies across 73 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benz's costs compare to other ophthalmologists in Houston?
Dr. Benz's average Medicare payment per service is $249. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →